Concepedia

Chau Thach

CT

Statistics

Publications

16

Citations

2.3K

H-Index

14

Active since

1998

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Washington

Université Paris Cité

Chau Thach is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1998–2018

16

Publications

16

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Jadwiga A. Wedzicha, Donald Banerji, Kenneth R. Chapman et al. · New England Journal of Medicine · 2016 · 870 citations · Full text

, , +17

C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly

Jie Cao, Chau Thach, Teri A. Manolio et al. · Circulation · 2003 · 326 citations · Full text

, , +15

Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly

Abraham A. Ariyo, Chau Thach, Russell P. Tracy · New England Journal of Medicine · 2003 · 285 citations · Full text

, , +14

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

Nicolás Roche, Kenneth R. Chapman, Claus Vogelmeier et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 166 citations

, , +17

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

Santanu Sannigrahi, Changzheng Wang, Xiangdong Zhou et al. · International Journal of COPD · 2015 · 162 citations · Full text

, , +17

1–5 of 16